Cutaneous Squamous Cell Carcinoma Risk of Recurrence Prediction

Trial – Castle Biosciences

Prospective Development and Validation of a Gene Expression Assay to Predict the Risk of Recurrence Disease in Cutaneous Squamous Cell Carcinoma

To participate in your local study, please contact  (949) 707-5734 or fill out the form below.


Share this post

Subscribe To Our Newsletter

Get updates and learn from the best

More To Explore

Call us, write us, or knock on our door.

Lorem ipsum dolor sit amet, consectetur adiop iscing elit, sed do eiusmod tempor inci didunt ult labore et dolore magna aliqua.